$20.3 Thousand is the total value of TLS Advisors LLC's 21 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EQT | New | EQT CORPORATION | $5,102 | – | 150,800 | +100.0% | 25.15% | – |
| OVID | New | OVID THERAPEUTICS INC | $2,772 | – | 1,490,534 | +100.0% | 13.66% | – |
| XOMA | New | XOMA CORP COM | $2,282 | – | 124,024 | +100.0% | 11.25% | – |
| FB | New | META PLATFORMS INC CLASS A COMMON STOCK COMMON STOCK | $1,756 | – | 14,589 | +100.0% | 8.66% | – |
| New | OMNIAB INC REG SHS COM | $1,392 | – | 386,592 | +100.0% | 6.86% | – | |
| SI | New | SILVERGATE CAPITAL CORP REGISTERE CL A | $1,388 | – | 79,795 | +100.0% | 6.84% | – |
| XENE | New | XENON PHARMACEUTICALS INC SHS | $1,331 | – | 33,756 | +100.0% | 6.56% | – |
| BLU | New | BELLUS HEALTH INC REG CORP | $1,034 | – | 125,731 | +100.0% | 5.10% | – |
| TSLA | New | TESLA INC COM | $739 | – | 6,000 | +100.0% | 3.64% | – |
| MEIP | New | MEI PHARMA INC | $490 | – | 2,010,285 | +100.0% | 2.42% | – |
| FSTX | New | F-STAR THERAPEUTICS INC COM | $343 | – | 54,298 | +100.0% | 1.69% | – |
| YNDX | New | YANDEX NV-A | $337 | – | 17,811 | +100.0% | 1.66% | – |
| HOV | New | HOVNANIAN ENTERPRISES INC COM | $272 | – | 6,472 | +100.0% | 1.34% | – |
| EWS | New | ISHARES MSCI SINGAPORE | $255 | – | 13,600 | +100.0% | 1.26% | – |
| AFMD | New | AFFIMED NV | $201 | – | 161,971 | +100.0% | 0.99% | – |
| REGN | New | REGENERON PHARMACEUTICALS INC | $180 | – | 250 | +100.0% | 0.89% | – |
| NKTX | New | NKARTA INC REG SHS COM | $161 | – | 26,842 | +100.0% | 0.79% | – |
| RRC | New | RANGE RESOURCES CORP | $150 | – | 59,823 | +100.0% | 0.74% | – |
| New | APTOSE BIOSCIENCES INC SHS | $52 | – | 89,403 | +100.0% | 0.26% | – | |
| NNDM | New | NANO DIMENSION LTD ADR | $51 | – | 22,000 | +100.0% | 0.25% | – |
| INKAW | New | KLUDEIN I ACQUISITION-CW27 | $1 | – | 10,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQT CORPORATION | 4 | Q3 2023 | 26.4% |
| OVID THERAPEUTICS INC | 4 | Q3 2023 | 20.5% |
| META PLATFORMS INC CLASS A COMMON STOCK COMMON STOCK | 4 | Q3 2023 | 13.0% |
| XOMA CORP COM | 4 | Q3 2023 | 13.1% |
| OMNIAB INC REG SHS COM | 4 | Q3 2023 | 6.9% |
| XENON PHARMACEUTICALS INC SHS | 4 | Q3 2023 | 6.6% |
| RANGE RESOURCES CORP | 4 | Q3 2023 | 8.1% |
| HOVNANIAN ENTERPRISES INC COM | 4 | Q3 2023 | 1.6% |
| ISHARES MSCI SINGAPORE ETF | 4 | Q3 2023 | 1.4% |
| YANDEX NV-A | 4 | Q3 2023 | 1.7% |
View TLS Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ovid Therapeutics Inc. | May 27, 2020 | 2,489,415 | 4.6% |
View TLS Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2020-05-27 |
| SC 13D/A | 2019-11-27 |
| SC 13D/A | 2019-10-07 |
| SC 13D | 2019-03-01 |
View TLS Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.